OneMedNet Corporation (ONMD) Stock

Understand OneMedNet Corporation: how it makes money

OneMedNet is a technology and business-services company that generated essentially no revenue in the latest reported quarter. It is deeply unprofitable, with its cost structure running many times above whatever minimal sales it records each period.

At current scale the company has no functioning profit model: every dollar of top line is followed by roughly twenty-seven dollars of operating cost, so the entire enterprise depends on external capital rather than unit economics.

Business quality (Unprofitable): Unprofitable. Revenue is negligible and both gross and operating margins are deeply negative, indicating the business has not yet found a sustainable commercial footing.

Bear case

• Cost of goods dwarfs revenue: Gross margin sits at -396%, meaning the direct cost of delivering the service runs roughly five times the minimal revenue it generates. At that ratio the core offering cannot sustain itself without continuous external funding.
• Operating losses compound each quarter: Operating margin of -2658% shows that total operating expenses are about twenty-seven times the company's revenue. Each additional quarter of operation deepens the cash burn before any product strategy can be validated at scale.

Related Companies (Business Services; 8 comparable business services companies)

• iSpecimen Inc. (ISPC)
• Absci Corporation (ABSI)
• bioAffinity Technologies, Inc. (BIAF)
• Q/C Technologies, Inc. (QCLS)
• VolitionRx Limited (VNRX)
• 20/20 Biolabs, Inc. Common Stock (AIDX)
• BNB Plus Corp. (BNBX)
• OmniAb, Inc. (OABI)